000258674 001__ 258674
000258674 005__ 20240309115311.0
000258674 0247_ $$2pmc$$apmc:PMC10334712
000258674 0247_ $$2doi$$a10.2196/45231
000258674 0247_ $$2pmid$$apmid:37314840
000258674 0247_ $$2altmetric$$aaltmetric:150001746
000258674 037__ $$aDZNE-2023-00647
000258674 041__ $$aEnglish
000258674 082__ $$a610
000258674 1001_ $$0P:(DE-2719)9000506$$aBudak, Beliz$$b0$$eFirst author
000258674 245__ $$aImplementing Active Assisted Living Technology in the Long-term Care of People Living With Dementia to Address Loneliness: European Survey.
000258674 260__ $$aToronto, ON$$bJMIR Publications Inc.$$c2023
000258674 3367_ $$2DRIVER$$aarticle
000258674 3367_ $$2DataCite$$aOutput Types/Journal article
000258674 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1689776398_1922
000258674 3367_ $$2BibTeX$$aARTICLE
000258674 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000258674 3367_ $$00$$2EndNote$$aJournal Article
000258674 520__ $$aIn the lives of people with dementia, loneliness is an important issue with psychological and physical consequences. Active assisted living (AAL) technology has been gaining visibility in the care of persons living with dementia, including addressing loneliness. However, to the best of our knowledge, there is a lack of evidence concerning the factors influencing the implementation of AAL technology within the context of dementia, loneliness, and long-term care (LTC).We aimed to identify the familiarity with AAL technology that is promising for addressing loneliness in persons living with dementia in LTC in Europe and the factors influencing AAL technology implementation.A web-based survey was developed based on findings from our previous literature review. The Consolidated Framework for Implementation Research guided the development and analysis of the survey. Participants included 24 representatives of Alzheimer Europe member associations from 15 European countries. The data were analyzed using basic statistical methods (descriptive statistics).The baby seal robot Paro was reported to be the most familiar AAL technology by 19 of 24 participants addressing loneliness in people with dementia living in LTC. Participants from Norway (n=2) reported familiarity with 14 AAL technologies, and participants from Serbia (n=1) reported zero familiarity. It seems that countries that invest less in LTC facilities are familiar with fewer AAL technologies. At the same time, these countries report a more positive attitude toward AAL technology, express a higher need for it, and see more advantages than disadvantages than those countries that invest more in LTC. However, a country's investment in LTC facilities does not seem to be linked to other implementation aspects such as costs, planning, and the impact of infrastructure.Implementation of AAL technology to address loneliness in dementia seems to be linked to familiarity with the technology in a country as well as national investment in LTC facilities. This survey confirms the literature on higher investment countries' critical stance in regard to AAL technology implementation to address loneliness in persons living with dementia living in LTC. Further research is needed to clarify the potential reasons why familiarity with more AAL technology does not seem to be directly linked with acceptance, positive attitude, or satisfaction with AAL technology addressing loneliness in persons living with dementia.
000258674 536__ $$0G:(DE-HGF)POF4-353$$a353 - Clinical and Health Care Research (POF4-353)$$cPOF4-353$$fPOF IV$$x0
000258674 588__ $$aDataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
000258674 650_7 $$2Other$$aAlzheimer
000258674 650_7 $$2Other$$aCFIR
000258674 650_7 $$2Other$$aactive assisted living technology
000258674 650_7 $$2Other$$adementia
000258674 650_7 $$2Other$$aimplementation
000258674 650_7 $$2Other$$aloneliness
000258674 650_7 $$2Other$$along-term care
000258674 650_7 $$2Other$$asocial isolation
000258674 7001_ $$0P:(DE-2719)2810469$$aLaporte Uribe, Franziska$$b1
000258674 7001_ $$0P:(DE-2719)9001232$$aMeiland, Franka$$b2
000258674 7001_ $$0P:(DE-2719)9000544$$aFelding, Simone$$b3
000258674 7001_ $$0P:(DE-2719)2812481$$aTeupen, Sonja$$b4
000258674 7001_ $$0P:(DE-2719)2812373$$aBergmann, Johannes$$b5
000258674 7001_ $$0P:(DE-2719)2810852$$aMüller-Widmer, Rene$$b6$$udzne
000258674 7001_ $$0P:(DE-2719)2810690$$aRoes, Martina$$b7$$eLast author
000258674 773__ $$0PERI:(DE-600)2985919-0$$a10.2196/45231$$gVol. 6, p. e45231 -$$pe45231$$tJMIR aging$$v6$$x2561-7605$$y2023
000258674 8564_ $$uhttps://aging.jmir.org/2023/1/e45231
000258674 8564_ $$uhttps://pub.dzne.de/record/258674/files/DZNE-2023-00647.pdf$$yOpenAccess
000258674 8564_ $$uhttps://pub.dzne.de/record/258674/files/DZNE-2023-00647.pdf?subformat=pdfa$$xpdfa$$yOpenAccess
000258674 909CO $$ooai:pub.dzne.de:258674$$popenaire$$popen_access$$pVDB$$pdriver$$pdnbdelivery
000258674 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9000506$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b0$$kDZNE
000258674 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2810469$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b1$$kDZNE
000258674 9101_ $$0I:(DE-HGF)0$$6P:(DE-2719)9001232$$aExternal Institute$$b2$$kExtern
000258674 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)9000544$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b3$$kDZNE
000258674 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2812481$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b4$$kDZNE
000258674 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2812373$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b5$$kDZNE
000258674 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2810852$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b6$$kDZNE
000258674 9101_ $$0I:(DE-588)1065079516$$6P:(DE-2719)2810690$$aDeutsches Zentrum für Neurodegenerative Erkrankungen$$b7$$kDZNE
000258674 9131_ $$0G:(DE-HGF)POF4-353$$1G:(DE-HGF)POF4-350$$2G:(DE-HGF)POF4-300$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bGesundheit$$lNeurodegenerative Diseases$$vClinical and Health Care Research$$x0
000258674 9141_ $$y2023
000258674 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-27
000258674 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000258674 915__ $$0StatID:(DE-HGF)0112$$2StatID$$aWoS$$bEmerging Sources Citation Index$$d2023-10-27
000258674 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJMIR AGING : 2022$$d2023-10-27
000258674 915__ $$0StatID:(DE-HGF)0501$$2StatID$$aDBCoverage$$bDOAJ Seal$$d2023-04-12T14:53:48Z
000258674 915__ $$0StatID:(DE-HGF)0500$$2StatID$$aDBCoverage$$bDOAJ$$d2023-04-12T14:53:48Z
000258674 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-27
000258674 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-27
000258674 915__ $$0StatID:(DE-HGF)9900$$2StatID$$aIF < 5$$d2023-10-27
000258674 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000258674 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bDOAJ : Peer review$$d2023-04-12T14:53:48Z
000258674 915__ $$0StatID:(DE-HGF)0561$$2StatID$$aArticle Processing Charges$$d2022-11-18
000258674 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-27
000258674 915__ $$0StatID:(DE-HGF)0320$$2StatID$$aDBCoverage$$bPubMed Central$$d2023-10-27
000258674 915__ $$0StatID:(DE-HGF)0700$$2StatID$$aFees$$d2022-11-18
000258674 9201_ $$0I:(DE-2719)1610003$$kAG Roes 2 ; AG Roes 2 ; AG Roes - IS$$lImplementation Science$$x0
000258674 9201_ $$0I:(DE-2719)5000076$$kAG Teupen$$lMethods in Health Care Research$$x1
000258674 980__ $$ajournal
000258674 980__ $$aVDB
000258674 980__ $$aUNRESTRICTED
000258674 980__ $$aI:(DE-2719)1610003
000258674 980__ $$aI:(DE-2719)5000076
000258674 9801_ $$aFullTexts